SCH 32651
Latest Information Update: 30 Aug 2002
Price :
$50 *
At a glance
- Originator Schering-Plough
- Class Antiulcers; Cytoprotectives
- Mechanism of Action Proton pump inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Peptic ulcer
Most Recent Events
- 31 May 1992 Discontinued for Peptic ulcer in USA (unspecified route)